Answers are grounded in this paper and cite their sources.
Partial nephrectomy (PN) is standard treatment for localized renal masses, balancing oncological efficacy with renal preservation. Although open partial nephrectomy (OPN), laparoscopic partial nephrectomy (LPN), and robot-assisted partial nephrectomy (RAPN) approaches are widely used, three-way comparisons remain limited in Latin America and across lesion complexity stratification. We compared perioperative, functional, and oncological outcomes among OPN, LPN, and RAPN in a Brazilian academic referral center. We retrospectively reviewed 499 consecutive patients undergoing PN for a solitary localized renal mass (2010–2023), analyzing demographic, perioperative, pathological, and functional data. Outcomes included operative time, warm ischemia time (WIT), blood loss, complications, length of stay, positive margins, creatinine variation, estimated glomerular filtration rate, recurrence rate, and trifecta achievement, with subgroup analysis by R.E.N.A.L. nephrometry score for intermediate/high-complexity tumors and multivariable analysis adjusted for tumour size, R.E.N.A.L. score, ASA class and lesion type. Among 499 patients, 191 underwent OPN, 255 LPN, and 53 RAPN. OPN showed shorter operative time (OT) ( p < 0.001) but higher estimated blood loss (EBL), longer length of stay (LOS) (both p < 0.001), and more postoperative complications of any grade ( p = 0.013). Positive surgical margins (PSM), major complications, and renal function did not differ among approaches; WIT did not differ among clamped procedures (medians 21, 21 and 19 min for OPN, RAPN and LPN; p = 0.093). Trifecta rates were higher for OPN (66.5%) and RAPN (62.3%) than LPN (53.7%, p = 0.023), with only the OPN–LPN pairwise difference significant. In intermediate/high-complexity lesions, RAPN achieved the numerically highest trifecta rate (69% vs. 46.2% for LPN and 62.3% for OPN; p = 0.027), with no pairwise difference after correction. RAPN achieved perioperative outcomes comparable to OPN, including in intermediate- and high-complexity tumors, where LPN underperformed. These findings support the feasibility of RAPN for complex renal masses and confirm safe implementation in a teaching institution without compromising surgical standards, but do not establish its superiority over OPN.
No takes yet. Share an insight, caveat, or question.
Paludo et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: